Oryzon Genomics plans to trade on MAB as a first step to Nasdaq
Oryzon Genomics se plantea cotizar en el MAB como paso previo para el Nasdaq
Intel ID : 219307
| Synopsis |
|
Catalonia-based Oryzon Genomics is considering an IPO on the Alternative Investement Market (Mercado Alternativo Bursátil - MAB) by mid November 2014, as a first step to then carry out a public offering on the US-based Nasdaq, in the next 18 to 24 months. In 2012, Oryzon Genomics initiated the procedure to go public, but finally the process was paralyzed due to the Spanish economic crisis and the difficulties the European markets were facing.
(content in spanish)
La empresa catalana Oryzon Genomics se plantea comenzar a cotizar en el Mercado Alternativo Bursátil (MAB) a mediados de noviembre de 2014, como paso previo a una posterior salida a cotización en el Nasdaq estadounidense en un plazo de entre 18 y 24 meses. En 2012 la empresa ya inició los trámites para salir a Bolsa, pero finalmente paralizó el proceso como consecuencia de la crisis de la economía española y de las dificultades que atravesaban los mercados bursátiles europeos. |
|
||||
| Intel ID | 219307 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Oryzon Genomics
(31 Dec 2022) |
Revenue: - Net Debt: - People: 44 |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
- |
|
|
 |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.